Do you or someone you know use Abbey St. Clare natural skin and beauty products? If so, you may have a claim for false labeling.
A product’s claims can trigger FDA regulations for a variety of reasons. In recent years, the Food and Drug Administration has issued warning letters to various personal care product manufacturers for false and misleading representations regarding their respective uses and effectiveness. Recently, the Food and Drug Administration issued a warning letter to Abbey St. Clare, the manufacturer of natural skin and beauty products. The FDA’s letter states that claims made by Abbey St. Clare are improper because they classify the products at issue as drugs and include unsubstantiated claims.
Finkelstein, Blankinship, Frei-Pearson & Garber, LLP is currently investigating this matter and other claims of false labeling of personal care products. If you or someone you know Abbey St. Clare products please contact us to discuss your legal options.